| Patent | Date |
|---|
Selective Ep4 Receptor Antagonistic Substance For Treatment Of Cancer
App 20220073510 - TAKE; Yukinori ; et al. | 2022-03-10 |
Grapiprant Unit Dosage Forms
App 20210353648 - MANFREDI; Mark ; et al. | 2021-11-18 |
Ep4 Inhibitors And Use Thereof
App 20210290641 - Manfredi; Mark ; et al. | 2021-09-23 |
EP4 inhibitors and use thereof
Grant 10,973,834 - Manfredi , et al. April 13, 2 | 2021-04-13 |
Selective EP4 receptor antagonistic substance for treatment of cancer
Grant 10,947,235 - Take , et al. March 16, 2 | 2021-03-16 |
Use of EP4 receptor antagonists in the treatment of cartilage disease
Grant 10,786,490 - Okumura September 29, 2 | 2020-09-29 |
Selective Ep4 Receptor Antagonistic Substance For Treatment Of Cancer
App 20200188367 - TAKE; Yukinori ; et al. | 2020-06-18 |
Selective EP4 receptor antagonistic substance for treatment of cancer
Grant 10,611,761 - Take , et al. | 2020-04-07 |
Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer
Grant 10,583,129 - Ohtani , et al. | 2020-03-10 |
Use Of Ep4 Receptor Antagonists For The Treatment Of Nash-associated Liver Cancer
App 20190365680 - OHTANI; Naoko ; et al. | 2019-12-05 |
Ep4 Inhibitors And Use Thereof
App 20190314390 - Manfredi; Mark ; et al. | 2019-10-17 |
Use Of Ep4 Receptor Antagonists For The Treatment Of Nash-associated Liver Cancer
App 20190269663 - OHTANI; Naoko ; et al. | 2019-09-05 |
Use of EP4 receptor antagonists in the treatment of cartilage disease
Grant 10,391,086 - Okumura A | 2019-08-27 |
Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer
Grant 10,342,785 - Ohtani , et al. July 9, 2 | 2019-07-09 |
Use Of Ep4 Receptor Antagonists In The Treatment Of Cartilage Disease
App 20180193324 - OKUMURA; Takako | 2018-07-12 |
Use Of Ep4 Receptor Antagonists For The Treatment Of Nash-associated Liver Cancer
App 20180125832 - OHTANI; Naoko ; et al. | 2018-05-10 |
Use Of Ep4 Receptor Antagonists In The Treatment Of Cartilage Disease
App 20170360764 - OKUMURA; Takako | 2017-12-21 |
Selective Ep4 Receptor Antagonistic Substance For Treatment Of Cancer
App 20170253595 - TAKE; Yukinori ; et al. | 2017-09-07 |
Selective EP4 receptor antagonistic substance for treatment of cancer
Grant 9,688,674 - Take , et al. June 27, 2 | 2017-06-27 |
Therapeutic agent for ocular disease
Grant 9,561,210 - Okumura , et al. February 7, 2 | 2017-02-07 |
Use Of Ep4 Receptor Antagonists In The Treatment Of Cartilage Disease
App 20160317514 - OKUMURA; Takako | 2016-11-03 |
Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases
Grant 9,457,084 - Kanazawa , et al. October 4, 2 | 2016-10-04 |
Salts and crystal forms
Grant 9,447,066 - Okumura , et al. September 20, 2 | 2016-09-20 |
Therapeutic Agent For Ocular Disease
App 20160008317 - OKUMURA; Takako ; et al. | 2016-01-14 |
Salts And Crystal Forms
App 20150353520 - OKUMURA; Yoshiyuki ; et al. | 2015-12-10 |
Selective Ep4 Receptor Antagonistic Substance For Treatment Of Cancer
App 20150111920 - TAKE; Yukinori ; et al. | 2015-04-23 |
Selective EP4 receptor antagonistic substance for treatment of cancer
Grant 8,921,391 - Take , et al. December 30, 2 | 2014-12-30 |
Use Of Ep4 Receptor Antagonists In The Treatment Of Il-23 Mediated Diseases
App 20120316197 - Kanazawa; Kiyoshi ; et al. | 2012-12-13 |
Selective Ep4 Receptor Agonistic Substance For Treatment Of Cancer
App 20120088723 - Take; Yukinori ; et al. | 2012-04-12 |
EP4 receptor inhibitors to treat rheumatoid arthritis
App 20020077329 - Audoly, Laurent ; et al. | 2002-06-20 |
| 